Clinical Trials Browser

Not yet recruiting × Esophageal Squamous Carcinoma × 90 days × Clear all

NCT07490002 2026-03-24

Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Squamous Carcinoma